Richard Grencis
Overview
Explore the profile of Richard Grencis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
291
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Multi-omics analysis in primary T cells elucidates mechanisms behind disease-associated genetic loci
Shi C, Zhao D, Butler J, Frantzeskos A, Rossi S, Ding J, et al.
Genome Biol
. 2025 Feb;
26(1):26.
PMID: 39930543
Background: Genome-wide association studies (GWAS) have uncovered the genetic basis behind many diseases and conditions. However, most of these genetic loci affect regulatory regions, making the interpretation challenging. Chromatin conformation...
2.
Petta I, Thorp M, Ciers M, Blancke G, Boon L, Meese T, et al.
Front Immunol
. 2024 Apr;
15:1373745.
PMID: 38680500
Background: Protective immunity against intestinal helminths requires induction of robust type-2 immunity orchestrated by various cellular and soluble effectors which promote goblet cell hyperplasia, mucus production, epithelial proliferation, and smooth...
3.
Saxton S, Whitley A, Potter R, Withers S, Grencis R, Heagerty A
Am J Physiol Heart Circ Physiol
. 2020 Oct;
319(6):H1387-H1397.
PMID: 33035443
Perivascular adipose tissue (PVAT) depots are metabolically active and play a major vasodilator role in healthy lean individuals. In obesity, they become inflamed and eosinophil-depleted and the anticontractile function is...
4.
Scott N, Andrusaite A, Andersen P, Lawson M, Alcon-Giner C, Leclaire C, et al.
Sci Transl Med
. 2018 Oct;
10(464).
PMID: 30355800
Macrophages in the healthy intestine are highly specialized and usually respond to the gut microbiota without provoking an inflammatory response. A breakdown in this tolerance leads to inflammatory bowel disease...
5.
Dhungana H, Malm T, Denes A, Valonen P, Wojciechowski S, Magga J, et al.
Aging Cell
. 2013 Jun;
12(5):842-50.
PMID: 23725345
Ischemic stroke is confounded by conditions such as atherosclerosis, diabetes, and infection, all of which alter peripheral inflammatory processes with concomitant impact on stroke outcome. The majority of the stroke...
6.
Denes A, Humphreys N, Lane T, Grencis R, Rothwell N
J Neurosci
. 2010 Jul;
30(30):10086-95.
PMID: 20668193
Infection and systemic inflammation are risk factors for cerebrovascular diseases and poststroke infections impair outcome in stroke patients, although the mechanisms of their contribution are mostly unknown. No preclinical studies...
7.
Hafez M, Hayes K, Goldrick M, Warhurst G, Grencis R, Roberts I
Infect Immun
. 2009 Apr;
77(7):2995-3003.
PMID: 19380467
Escherichia coli strain Nissle 1917 has been widely used as a probiotic for the treatment of inflammatory bowel disorders and shown to have immunomodulatory effects. Nissle 1917 expresses a K5...
8.
Rowland C, Lertmemongkolchai G, Bancroft A, Haque A, Lever M, Griffin K, et al.
Infect Immun
. 2006 Aug;
74(9):5333-40.
PMID: 16926428
Burkholderia mallei is a gram-negative bacterium which causes the potentially fatal disease glanders in humans; however, there is little information concerning cell-mediated immunity to this pathogen. The role of gamma...
9.